Sugi Predict

Sugi Predict / Compounds / SCHEMBL977022

SCHEMBL977022

SCHEMBL977022

COC(=O)c1cc(F)cc(NS(=O)(=O)CC2CN(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)C2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A9 P48067 2/20 0.37
▸ ATM Q13315 1/20 0.37
▸ SCN9A Q15858 4/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ GPX4 P36969 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ HPGD P15428 1/20 0.34
▸ OPRD1 P41143 2/20 0.34
▸ CNR1 P21554 1/20 0.34
▸ SCN7A Q01118 1/20 0.34
▸ SCN5A Q14524 1/20 0.34
▸ P2RX3 P56373 1/20 0.34
▸ MDM2 Q00987 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ GRIA2 P42262 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL975372 0.93 KDM4E (0.41) ATMSCN9AMEN1LMNAKMT2A
SCHEMBL978430 0.92 HPGD (0.38) SLC6A9SCN9ALMNAMAPTHPGD
SCHEMBL979322 0.92 TCF4 (0.37) SLC6A9SCN9AMEN1LMNAKMT2A
SCHEMBL975275 0.92 SLC6A9 (0.39) SLC6A9ATMMEN1LMNAKMT2A
SCHEMBL974202 0.90 WDR5 (0.41) SLC6A9SCN9ALMNAGPX4CNR1
SCHEMBL977237 0.89 SLC6A9 (0.37) SLC6A9ATMMEN1LMNAKMT2A
SCHEMBL975711 0.89 SLC6A9 (0.37) SLC6A9ATMSCN9AMEN1LMNA
SCHEMBL977906 0.88 ACHE (0.42) SCN9AMEN1LMNAKMT2AOPRD1
SCHEMBL976058 0.88 ATM (0.38) SLC6A9ATMCNR1
SCHEMBL977439 0.87 SCN9A (0.36) SLC6A9SCN9ASCN7ASCN5AP2RX3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130237513-A1 AZETIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY SANOFI (FR) 2013-09-12 — — US claimed
EP-2234966-B1 AZETIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY SANOFI SA (FR) 2013-09-11 — — EP claimed
US-20110009377-A1 AZETIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY SANOFI-AVENTIS (FR) 2011-01-13 — — US claimed
US-20130237513-A1 AZETIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY SANOFI (FR) 2013-09-12 — — US disclosed
US-8445478-B2 Azetidine derivatives, their preparation and their application in therapy SANOFI (FR) 2013-05-21 — — US disclosed
US-20110009377-A1 AZETIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY SANOFI-AVENTIS (FR) 2011-01-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130237513-A1 AZETIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY QDPR, AZI2, ADRA1B SLC6A9 2158/4885ATM 3498/4885SCN9A 694/4885
US-20110009377-A1 AZETIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY QDPR, AZI2, ADRA1B SLC6A9 2158/4885ATM 3498/4885SCN9A 694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.